$SIGA
SIGA Technologies Inc Stock $siga

$siga Overview Financials Valuation SEC Filings Company Website

2019 Q4 Form 10-Q Financial Statement

#000101008619000018 Filed on November 05, 2019

Income Statement

Concept	2019 Q4	2019 Q3	2018 Q3
Revenue	$4.264M	$8.111M	$471.1M
YoY Change	171.77%	-98.28%	33790.29%
Cost Of Revenue	$130.0K	$737.0K	$95.17M
YoY Change	26.21%	-99.23%
Gross Profit	$4.134M	$7.374M	$375.9M
YoY Change	181.99%	-98.04%	26943.81%
Gross Profit Margin	96.95%	90.91%	79.8%
Selling, General & Admin	$3.497M	$3.196M	$3.115M
YoY Change	-8.65%	2.61%	0.68%
% of Gross Profit	84.59%	43.35%	0.83%
Research & Development	$3.924M	$3.344M	$3.723M
YoY Change	31.99%	-10.19%	50.67%
% of Gross Profit	94.92%	45.34%	0.99%
Depreciation & Amortization	$130.0K	$130.3K	$14.71K
YoY Change	550.0%	785.46%	-49.92%
% of Gross Profit	3.14%	1.77%	0.0%
Operating Expenses	$7.421M	$7.451M	$102.2M
YoY Change	9.12%	-92.71%	1351.35%
Operating Profit	-$3.470M	$660.6K	$368.9M
YoY Change	-37.38%	-99.82%	-6627.78%
Interest Expense	-$3.600M	$3.972M	$3.924M
YoY Change	-35.71%	1.22%	5.0%
% of Operating Profit		601.28%	1.06%
Other Income/Expense, Net	$600.0K	$759.9K	$5.067K
YoY Change	-99.24%	14896.66%	150.72%
Pretax Income	-$6.500M	-$1.570M	$362.6M
YoY Change	-109.62%	-100.43%	3638.53%
Income Tax	-$2.000M	-$400.0K	-$25.41M
% Of Pretax Income			-7.01%
Net Earnings	-$4.503M	-$1.206M	$388.1M
YoY Change	-108.59%	-100.31%	-4053.24%
Net Earnings / Revenue	-105.61%	-14.87%	82.38%
Basic Earnings Per Share	-$0.06	-$0.01	$4.85
Diluted Earnings Per Share	-$0.06	-$0.03	$4.71
COMMON SHARES
Basic Shares Outstanding	80.94M shares	81.06M	80.02M shares
Diluted Shares Outstanding		82.18M	82.93M shares

Balance Sheet

Concept	2019 Q4	2019 Q3	2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$65.20M	$78.10M	$104.0M
YoY Change	-35.25%	-24.9%	303.1%
Cash & Equivalents	$65.25M	$78.10M	$104.0M
Short-Term Investments
Other Short-Term Assets	$100.9M	$13.40M	$5.200M
YoY Change	538.61%	157.69%	-54.78%
Inventory	$9.653M	$3.931M	$2.908M
Prepaid Expenses
Receivables	$4.168M	$3.218M	$1.540M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$180.0M	$98.62M	$113.7M
YoY Change	48.44%	-13.23%	177.94%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.618M	$2.750M	$117.9K
YoY Change	1428.72%	2232.99%	-1.56%
Goodwill	$898.3K	$898.3K	$898.3K
YoY Change	0.0%	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$856.8K	$863.0K	$1.095M
YoY Change	-19.09%	-21.2%	70.57%
Total Long-Term Assets	$18.52M	$104.4M	$30.06M
YoY Change	-77.45%	247.23%	-72.12%
TOTAL ASSETS
Total Short-Term Assets	$180.0M	$98.62M	$113.7M
Total Long-Term Assets	$18.52M	$104.4M	$30.06M
Total Assets	$198.6M	$203.0M	$143.7M
YoY Change	-2.4%	41.25%	-3.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.054M	$2.252M	$894.8K
YoY Change	80.87%	151.66%	-34.32%
Accrued Expenses	$8.637M	$9.544M	$4.311M
YoY Change	-10.49%	121.39%	-0.23%
Deferred Revenue	$2.298M
YoY Change
Short-Term Debt	$80.04M	$0.00	$0.00
YoY Change
Long-Term Debt Due	$80.00M
YoY Change
Total Short-Term Liabilities	$91.74M	$11.80M	$5.206M
YoY Change	709.14%	126.59%	-60.07%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$78.90M	$74.40M
YoY Change	-100.0%	6.05%	6.44%
Other Long-Term Liabilities	$9.000M	$9.400M	$11.60M
YoY Change	-33.82%	-18.97%	-96.93%
Total Long-Term Liabilities	$9.000M	$88.30M	$86.00M
YoY Change	-89.9%	2.67%	-80.81%
TOTAL LIABILITIES
Total Short-Term Liabilities	$91.74M	$11.80M	$5.206M
Total Long-Term Liabilities	$9.000M	$88.30M	$86.00M
Total Liabilities	$100.8M	$100.1M	$91.25M
YoY Change	0.25%	9.74%	-80.23%
SHAREHOLDERS EQUITY
Retained Earnings	-$123.0M	-$118.5M	-$168.2M
YoY Change	6.25%	-29.52%	-68.09%
Common Stock	$220.8M	$221.4M	$220.7M
YoY Change	0.96%	0.34%	2.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$97.78M	$102.9M	$52.47M
YoY Change
Total Liabilities & Shareholders Equity	$198.6M	$203.0M	$143.7M
YoY Change	-2.4%	41.25%	-3.36%

Cashflow Statement

Concept	2019 Q4	2019 Q3	2018 Q3
OPERATING ACTIVITIES
Net Income	-$4.503M	-$1.206M	$388.1M
YoY Change	-108.59%	-100.31%	-4053.24%
Depreciation, Depletion And Amortization	$130.0K	$130.3K	$14.71K
YoY Change	550.0%	785.46%	-49.92%
Cash From Operating Activities	-$14.26M	$400.0K	$86.21M
YoY Change	297.21%	-99.54%	-1231.36%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	-$20.00K	$0.00
YoY Change	-100.0%		-100.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00
YoY Change	-100.0%
Cash From Investing Activities	$0.00	-$20.00K	$0.00
YoY Change	-100.0%		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-980.0K	-140.0K	-1.450M
YoY Change	-58.3%	-90.34%
NET CHANGE
Cash From Operating Activities	-14.26M	400.0K	86.21M
Cash From Investing Activities	0.000	-20.00K	0.000
Cash From Financing Activities	-980.0K	-140.0K	-1.450M
Net Change In Cash	-15.24M	240.0K	84.76M
YoY Change	-121.07%	-99.72%	-1210.88%
FREE CASH FLOW
Cash From Operating Activities	-$14.26M	$400.0K	$86.21M
Capital Expenditures	$0.00	-$20.00K	$0.00
Free Cash Flow	-$14.26M	$420.0K	$86.21M
YoY Change	305.11%	-99.51%	-1232.85%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
	dei	Document Period End Date DocumentPeriodEndDate	2019-09-30
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001010086
CY2019Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	80941524	shares
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	SIGA TECHNOLOGIES INC
	dei	Entity Shell Company EntityShellCompany	false
	dei	Entity Small Business EntitySmallBusiness	false
CY2018Q4	siga	Accrued Researchand Development Vendor Costs Current AccruedResearchandDevelopmentVendorCostsCurrent	1446410	USD
CY2019Q3	siga	Accrued Researchand Development Vendor Costs Current AccruedResearchandDevelopmentVendorCostsCurrent	517618	USD
CY2019Q3	siga	Amount Received From Contractfor Developmentand Support Activities AmountReceivedFromContractforDevelopmentandSupportActivities	45000000	USD
CY2018Q4	siga	Computer Equipment Gross ComputerEquipmentGross	618248	USD
CY2019Q3	siga	Computer Equipment Gross ComputerEquipmentGross	601797	USD
CY2011Q2	siga	Contract Value Detail Of Option Exercisable Development Activities ContractValueDetailOfOptionExercisableDevelopmentActivities	58300000	USD
CY2019Q1	siga	Contract Value Detail Of Option Exercisable Development Activities ContractValueDetailOfOptionExercisableDevelopmentActivities	25800000	USD
CY2011Q2	siga	Contract Value Detail Of Option Exercisable Production Activities ContractValueDetailOfOptionExercisableProductionActivities	14400000	USD
CY2018Q3	siga	Contract Value Detail Of Option Exercisable Production Activities ContractValueDetailOfOptionExercisableProductionActivities	525000000	USD
	siga	Contract Value Option Fda Approval ContractValueOptionFDAApproval	50000000	USD
CY2011Q2	siga	Contract Valueof Various Options ContractValueofVariousOptions	72700000	USD
	siga	Conversionof Warrantsto Common Stock ConversionofWarrantstoCommonStock	6007847	USD
	siga	Conversionof Warrantsto Common Stock ConversionofWarrantstoCommonStock	1172801	USD
CY2018Q3	siga	Discrete Tax Benefit DiscreteTaxBenefit	25800000	USD
CY2018Q3	siga	Gain Lossfrom Changein Fair Valueof Warrant GainLossfromChangeinFairValueofWarrant	-2328674	USD
	siga	Gain Lossfrom Changein Fair Valueof Warrant GainLossfromChangeinFairValueofWarrant	-5271503	USD
CY2019Q3	siga	Gain Lossfrom Changein Fair Valueof Warrant GainLossfromChangeinFairValueofWarrant	981923	USD
	siga	Gain Lossfrom Changein Fair Valueof Warrant GainLossfromChangeinFairValueofWarrant	4774711	USD
CY2018Q3	siga	Government Contract Base Valueof Award For Deliveryof Courses GovernmentContractBaseValueofAwardForDeliveryofCourses	11100000	USD
CY2018Q3	siga	Government Contract Number Of Courses Purchased Under Modified Contract GovernmentContractNumberOfCoursesPurchasedUnderModifiedContract	1700000	contract
CY2011Q2	siga	Government Contract Numberof Additional Courses Purchased Under Modified Contract GovernmentContractNumberofAdditionalCoursesPurchasedUnderModifiedContract	300000	course
	siga	Government Contract Numberof Paymentstobe Paid Upon Deliveryof Bulk Drug Substance GovernmentContractNumberofPaymentstobePaidUponDeliveryofBulkDrugSubstance	3200000	USD
CY2018Q3	siga	Government Contract Paymentsfor Supportive Procurement Activities GovernmentContractPaymentsforSupportiveProcurementActivities	600000	USD
CY2011Q2	siga	Government Contract Value Of Award1 GovernmentContractValueOfAward1	508700000	USD
CY2018Q3	siga	Government Contract Value Of Award1 GovernmentContractValueOfAward1	602500000	USD
	siga	Government Contract Value Of Award1 GovernmentContractValueOfAward1	32000000	USD
CY2018Q3	siga	Governmentcontractbasevalueawardfordeliveryandsupportactivities Governmentcontractbasevalueawardfordeliveryandsupportactivities	51700000	USD
	siga	Increase In Fair Value Of Warrants IncreaseInFairValueOfWarrants	5271503	USD
	siga	Increase In Fair Value Of Warrants IncreaseInFairValueOfWarrants	-4774711	USD
CY2018Q3	siga	Number Of Courses To Be Delivered1 NumberOfCoursesToBeDelivered1	1488000	course
CY2018Q3	siga	Numberof Courses Delivered Options Final Drug Product NumberofCoursesDeliveredOptionsFinalDrugProduct	35700	course
CY2019Q2	siga	Numberof Courses Dividedinto Procurement Related Options NumberofCoursesDividedintoProcurementRelatedOptions	363070	course
	siga	Numberof Courses Options Final Drug Product NumberofCoursesOptionsFinalDrugProduct	20000	course
CY2018Q3	siga	Numberof Courses Storedas Vendor Managed Inventory NumberofCoursesStoredasVendorManagedInventory	212000	course
CY2019Q1	siga	Numberof Coursesthat Paymentwas Receivedfor NumberofCoursesthatPaymentwasReceivedfor	36000	course
CY2018Q3	siga	Numberof Primary Manufacturing Steps NumberofPrimaryManufacturingSteps	2	step
CY2019Q3	siga	Numberof Renewal Options NumberofRenewalOptions	2	option
CY2018Q3	siga	Numberofcoursesbasefinaldrugproduct Numberofcoursesbasefinaldrugproduct	8000000	USD
CY2018Q3	siga	Patent Preparation Fees PatentPreparationFees	186028	USD
	siga	Patent Preparation Fees PatentPreparationFees	582833	USD
CY2019Q3	siga	Patent Preparation Fees PatentPreparationFees	173580	USD
	siga	Patent Preparation Fees PatentPreparationFees	543806	USD
CY2019Q2	siga	Paymentfor Procurementof Raw Materials PaymentforProcurementofRawMaterials	11200000	USD
CY2019Q3	siga	Proceeds From Manufacture And Physical Delivery Of Courses Government Contracts ProceedsFromManufactureAndPhysicalDeliveryOfCoursesGovernmentContracts	459800000	USD
CY2019Q1	siga	Proceedsfor Deliveryof Courses ProceedsforDeliveryofCourses	11100000	USD
CY2019Q2	siga	Proceedsfor Deliveryof Courses ProceedsforDeliveryofCourses	34000000	USD
CY2018Q4	siga	Proceedsfrom Saleof Priority Review Voucher ProceedsfromSaleofPriorityReviewVoucher	78300000	USD
CY2018Q4	siga	Rightof Use Asset Gross RightofUseAssetGross	0	USD
CY2019Q3	siga	Rightof Use Asset Gross RightofUseAssetGross	2944932	USD
	siga	Stock Issuance Fees Expense StockIssuanceFeesExpense	3363712	USD
	siga	Stock Issuance Fees Expense StockIssuanceFeesExpense	3363712	USD
CY2018Q3	siga	Stock Issued During Period Value Restricted Stock Unitsand Stock Settled Appreciation Rights Exercised StockIssuedDuringPeriodValueRestrictedStockUnitsandStockSettledAppreciationRightsExercised	0	USD
	siga	Stock Issued During Period Value Restricted Stock Unitsand Stock Settled Appreciation Rights Exercised StockIssuedDuringPeriodValueRestrictedStockUnitsandStockSettledAppreciationRightsExercised	0	USD
	siga	Stock Issued During Period Value Restricted Stock Unitsand Stock Settled Appreciation Rights Exercised StockIssuedDuringPeriodValueRestrictedStockUnitsandStockSettledAppreciationRightsExercised	0	USD
CY2018Q3	siga	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	6007847	USD
	siga	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	6007847	USD
CY2019Q3	siga	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	0	USD
	siga	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	1172801	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1688488	USD
CY2019Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2251814	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1959133	USD
CY2019Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3217701	USD
CY2018Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	2600839	USD
CY2019Q3	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	2016001	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9648917	USD
CY2019Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9544060	USD
CY2018Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	242043	USD
CY2019Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	368218	USD
CY2018Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	294794	USD
CY2019Q3	us-gaap	Accrued Vacation Current AccruedVacationCurrent	297103	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3244861	USD
CY2019Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3594858	USD
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	218697872	USD
CY2019Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	221388212	USD
CY2018Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1176558	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1866279	USD
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	761096	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1717380	USD
CY2018Q4	us-gaap	Assets Assets	203443741	USD
CY2019Q3	us-gaap	Assets Assets	203011437	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	121289845	USD
CY2019Q3	us-gaap	Assets Current AssetsCurrent	98621732	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19857833	USD
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	103985265	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	100652809	USD
CY2019Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	78095231	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	37101586	USD
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	108080634	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	180396910	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	176228005	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	70979048	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-4168905	USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2019Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	80763350	shares
CY2019Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	81074280	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	80763350	shares
CY2019Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	81074280	shares
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	8076	USD
CY2019Q3	us-gaap	Common Stock Value CommonStockValue	8107	USD
	us-gaap	Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Modification Of Contract ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueModificationOfContract	3300000	USD
	us-gaap	Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized	1000000	USD
CY2018Q3	us-gaap	Cost Of Revenue CostOfRevenue	95166271	USD
	us-gaap	Cost Of Revenue CostOfRevenue	95166271	USD
CY2019Q3	us-gaap	Cost Of Revenue CostOfRevenue	737274	USD
	us-gaap	Cost Of Revenue CostOfRevenue	1652641	USD
CY2017Q4	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	-223313	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-25520615	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1065675	USD
CY2018Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4159946	USD
CY2019Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4112007	USD
CY2018Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	11733385	USD
CY2019Q3	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	12799060	USD
CY2018Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	14710	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	48639	USD
CY2019Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	130251	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	395540	USD
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.85
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.64
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.71
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.53
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2018Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0701
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0739
CY2019Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.2317
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.2630
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-4774711	USD
CY2018Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	12380939	USD
CY2019Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	6433427	USD
CY2018Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	377859	USD
CY2019Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	377859	USD
CY2018Q4	us-gaap	Goodwill Goodwill	898334	USD
CY2019Q3	us-gaap	Goodwill Goodwill	898334	USD
CY2018Q3	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	362637418	USD
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	344004396	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1569569	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-3715820	USD
CY2018Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-25412995	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-25412498	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-977278	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-363742	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-969951	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-697325	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-369872	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1258568	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-47939	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	0	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1022951	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-567042	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-2189076	USD
CY2018Q3	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	2906432	shares
	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	3093854	shares
CY2019Q3	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	1116931	shares
	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	1159520	shares
CY2018Q3	us-gaap	Interest Expense InterestExpense	3924124	USD
	us-gaap	Interest Expense InterestExpense	11516103	USD
CY2019Q3	us-gaap	Interest Expense InterestExpense	3971952	USD
	us-gaap	Interest Expense InterestExpense	11871401	USD
CY2018Q4	us-gaap	Interest Payable Current InterestPayableCurrent	35567	USD
CY2019Q3	us-gaap	Interest Payable Current InterestPayableCurrent	968018	USD
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	957765	USD
CY2019Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	960979	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	2908210	USD
CY2019Q3	us-gaap	Inventory Net InventoryNet	3931161	USD
CY2018Q4	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	1950445	USD
CY2019Q3	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	2970182	USD
CY2018Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	2420028	USD
CY2019Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	2420028	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3446692	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	1387139	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	402078	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	368467	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	600362	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	591108	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	97538	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	515980	USD
CY2018Q4	us-gaap	Liabilities Liabilities	100529054	USD
CY2019Q3	us-gaap	Liabilities Liabilities	100144921	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	203443741	USD
CY2019Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	203011437	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11337405	USD
CY2019Q3	us-gaap	Liabilities Current LiabilitiesCurrent	11795874	USD
CY2018Q4	us-gaap	Long Term Debt LongTermDebt	75547597	USD
CY2019Q3	us-gaap	Long Term Debt LongTermDebt	78911307	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1455611	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-199810	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-27863	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-29092	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	72462522	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3940003	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	388050413	USD
	us-gaap	Net Income Loss NetIncomeLoss	369416894	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-1205827	USD
	us-gaap	Net Income Loss NetIncomeLoss	-2738542	USD
CY2018Q3	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	390379087	USD
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	374688397	USD
CY2019Q3	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-2187750	USD
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-7513253	USD
CY2018Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5067	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	151454	USD
CY2019Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	759881	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2233588	USD
CY2018Q3	us-gaap	Operating Expenses OperatingExpenses	102190175	USD
	us-gaap	Operating Expenses OperatingExpenses	114843926	USD
CY2019Q3	us-gaap	Operating Expenses OperatingExpenses	7450745	USD
	us-gaap	Operating Expenses OperatingExpenses	21330737	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	368885149	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	360640548	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	660579	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	1147282	USD
CY2018Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	200000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	500000	USD
CY2019Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	0	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	0	USD
CY2019Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	2930712	USD
CY2018Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	USD
CY2019Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	412436	USD
CY2018Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	100000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	400000	USD
CY2019Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	0	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	0	USD
CY2019Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0453
CY2019Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y5M9D
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	3019928	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	541376	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	352000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	320774	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	304000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	304000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	1197778	USD
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	869318	USD
CY2019Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	852659	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1058880	USD
CY2019Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	862979	USD
CY2018Q4	us-gaap	Other Liabilities OtherLiabilities	1263113	USD
CY2019Q3	us-gaap	Other Liabilities OtherLiabilities	3004313	USD
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	27863	USD
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	29092	USD
	us-gaap	Payments For Restructuring PaymentsForRestructuring	294351	USD
CY2018Q3	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1695962	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1708290	USD
CY2019Q3	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	143220	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	199810	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4317615	USD
CY2019Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2324439	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	252679	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1172801	USD
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3416135	USD
CY2019Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6344616	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	171274	USD
CY2019Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2749758	USD
	us-gaap	Recognition Of Deferred Revenue RecognitionOfDeferredRevenue	281950853	USD
	us-gaap	Recognition Of Deferred Revenue RecognitionOfDeferredRevenue	0	USD
	us-gaap	Related Party Costs RelatedPartyCosts	50000	USD
CY2018Q4	us-gaap	Related Party Transaction Due From To Related Party RelatedPartyTransactionDueFromToRelatedParty	200000	USD
CY2019Q3	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	50000	USD
	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	150000	USD
CY2018Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3723198	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10043205	USD
CY2019Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3343521	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9379125	USD
CY2018Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	11452078	USD
CY2019Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	11053200	USD
CY2018Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	68292023	USD
CY2019Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	87079574	USD
CY2017Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	10701305	USD
CY2018Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	4095369	USD
CY2018Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	11452078	USD
CY2019Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	11053200	USD
CY2017Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	6542448	USD
CY2018Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	0	USD
CY2018Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	68292023	USD
CY2019Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	87079574	USD
	us-gaap	Restructuring Charges RestructuringCharges	30764	USD
CY2018Q4	us-gaap	Restructuring Reserve RestructuringReserve	509937	USD
CY2019Q3	us-gaap	Restructuring Reserve RestructuringReserve	246350	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-115791261	USD
CY2019Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-118529803	USD
CY2018Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	471075324	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	475484474	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8111324	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	22478019	USD
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82181858	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82744227	shares
CY2018Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	36100000	USD
CY2018Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3114678	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9051617	USD
CY2019Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3196370	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9755165	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1866279	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1717380	USD
	us-gaap	Stock Issued1 StockIssued1	1582420	USD
	us-gaap	Stock Issued1 StockIssued1	118500	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	USD
CY2018Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	252679	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	252679	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	-323138291	USD
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	-341317730	USD
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	52473805	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	102914687	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	103454467	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	102866516	USD
CY2018Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	12380939	USD
CY2019Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	6433427	USD
CY2018Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82929476	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82148333	shares
CY2018Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80023044	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79650373	shares
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	81064927	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80988813	shares

Files In Submission

Name	View Source	Status
0001010086-19-000018-index-headers.html	Edgar Link	pending
0001010086-19-000018-index.html	Edgar Link	pending
0001010086-19-000018.txt	Edgar Link	pending
0001010086-19-000018-xbrl.zip	Edgar Link	pending
exhibit101-mod0003redacted.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
siga-20190930.xml	Edgar Link	completed
siga-20190930.xsd	Edgar Link	pending
siga-20190930x10q.htm	Edgar Link	pending
siga-20190930_cal.xml	Edgar Link	unprocessable
siga-20190930_def.xml	Edgar Link	unprocessable
siga-20190930_lab.xml	Edgar Link	unprocessable
siga-20190930_pre.xml	Edgar Link	unprocessable
siga-exhibit3112019q31.htm	Edgar Link	pending
siga-exhibit3122019q31.htm	Edgar Link	pending
siga-exhibit3212019q31.htm	Edgar Link	pending
siga-exhibit3222019q31.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SIGA
SIGA Technologies Inc Stock $siga

2019 Q4 Form 10-Q Financial Statement

#000101008619000018 Filed on November 05, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SIGA SIGA Technologies Inc Stock $siga

2019 Q4 Form 10-Q Financial Statement

#000101008619000018 Filed on November 05, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SIGA
SIGA Technologies Inc Stock $siga